Template:COVID-19 pandemic data/Treatments given
Jump to navigation
Jump to search
Treatments for 2019-nCoV at Wuhan Jinyintan Hospital, 2020 January[1] ( ) | ||
---|---|---|
Oxygen therapy | 75 | 76% |
Antivirals | 75 | 76% |
Antibiotics | 70 | 71% |
Intravenous immunoglobulin | 27 | 27% |
Glucocorticoids | 19 | 19% |
Mechanical ventilation | 17 | 17% |
Antifungals | 15 | 15% |
CRRT | 9 | 9% |
ECMO | 3 | 3% |
Patients n=99. "Treatment" refers to palliative care intended to ease symptoms and fight complications. |
References
- ↑ Chen, Nanshan; Zhou, Min; Dong, Xuan; Qu, Jieming; Gong, Fengyun; Han, Yang; Qiu, Yang; Wang, Jingli; Liu, Ying; Wei, Yuan; Xia, Jia'an; Yu, Ting; Zhang, Xinxin; Zhang, Li (30 January 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". The Lancet. doi:10.1016/S0140-6736(20)30211-7.